These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2886354)

  • 21. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment.
    White FJ; Wang RY
    Brain Res; 1984 Sep; 309(2):283-92. PubMed ID: 6478223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroquel: electrophysiological profile of a potential atypical antipsychotic.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Psychopharmacology (Berl); 1993; 112(2-3):293-8. PubMed ID: 7871033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR; Budygin EA; Kovalev GI; Kudrin VS; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(7):47-9. PubMed ID: 1358258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
    Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY
    Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):673-80. PubMed ID: 2567348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.
    Rasmussen K; Howbert JJ; Stockton ME
    Synapse; 1993 Oct; 15(2):95-103. PubMed ID: 8259526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.
    Henry DJ; Greene MA; White FJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):833-9. PubMed ID: 2557418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.
    Beninger RJ; Cheng M; Hahn BL; Hoffman DC; Mazurski EJ; Morency MA; Ramm P; Stewart RJ
    Psychopharmacology (Berl); 1987; 92(3):343-9. PubMed ID: 2957718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 5-HT3 receptor antagonists LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells.
    Minabe Y; Ashby CR; Schwartz JE; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):143-50. PubMed ID: 1665793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
    Blackburn JR; Phillips AG
    Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine and preparatory behavior: III. Effects of metoclopramide and thioridazine.
    Blackburn JR; Phillips AG; Fibiger HC
    Behav Neurosci; 1989 Aug; 103(4):903-6. PubMed ID: 2765192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.
    Gessa GL; Porceddu ML; Collu M; Mereu G; Serra M; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Feb; 109(2):269-74. PubMed ID: 2859998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.